Hemoglobin Oxygen Therapeutics' Unattributed - II Round

Hemoglobin Oxygen Therapeutics raised a round of funding on April 13, 2015.

Hemoglobin Oxygen Therapeutics has developed two hemoglobin-based products: Hemopure (Hemoglobin Glutamer 250) for human application and Oxyglobin (Hemoglobin Glutamer 200) for veterinary application.…

Articles about Hemoglobin Oxygen Therapeutics' Unattributed - II Round: